Philips Appoints Deborah DiSanzo as New CEO of the Healthcare Sector

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) announced the appointment of Deborah DiSanzo as Chief Executive Officer of Philips Healthcare and member of its Executive Committee, with effect from May 1, 2012. Mrs. DiSanzo will succeed Steve Rusckowski, who will leave the company per April 30, 2012.

"I'm happy that with Deborah DiSanzo we have found a strong leader for Healthcare within our own organization," said Frans van Houten, Chief Executive Officer of Philips. "Deborah has a proven track record within the healthcare industry and has grown the Patient Care and Clinical Informatics (PCCI) business to become the global market leader in patient monitoring."

"At the same time I thank Steve for his long-term contribution to Philips," Van Houten continued. "During his leadership of our Healthcare sector, Philips strengthened its position in the industry in growth geographies and through targeted acquisitions such as in Home Healthcare. Steve has been a great supporter and I regret to see him go. I wish him all the best in his new role."

"I look very much forward to become a member of the Philips Executive Committee and CEO of Philips Healthcare," said Mrs. DiSanzo. "We have a strong foundation and are well positioned to grasp growth opportunities for Philips Healthcare in all phases of the care cycle, driven by our strong and meaningful innovation."

"After more than ten years with Philips, I am ready to take on a new challenge in the healthcare industry," said Steve Rusckowski, Chief Executive Officer of Philips Healthcare. "I'm proud of all the people within the Healthcare sector that grew our business into one of the leading medical device players. I am pleased that Deborah DiSanzo is succeeding me and I’m confident that Philips Healthcare under her leadership will further strengthen its position."

Mrs. DiSanzo, born in 1960 in the United States, joined Philips in 2001 when Philips acquired Agilent's Healthcare Solutions Group. She became General Manager of Patient Monitoring in June 2006 and CEO of Healthcare Informatics and Patient Monitoring in June 2008. In April 2010, Deborah DiSanzo became CEO of Patient Care and Clinical Informatics (PCCI).

Mr. Rusckowski, born in 1957 in the United States, joined Philips in 2001 when Philips acquired Agilent's Healthcare Solutions Group. In November 2006, he became Chief Executive Officer of Philips Healthcare.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...